Bill 119 hr 87, also known as the "COVID-19 Vaccine Transparency Act," aims to amend the Public Health Service Act to prevent the Secretary of Health and Human Services from adding any COVID-19 vaccine to the child and adolescent immunization schedule without first making all clinical data regarding the safety and effectiveness of the vaccine publicly available on the Centers for Disease Control and Prevention website.
The bill requires the Secretary to disclose all clinical data in the possession of the Department of Health and Human Services related to the safety and efficacy of the COVID-19 vaccine before it can be recommended for use in children and adolescents. This transparency is intended to ensure that the public has access to all relevant information before making decisions about vaccination.
In addition to promoting transparency, the bill also serves other purposes related to ensuring the safety and efficacy of COVID-19 vaccines for children and adolescents. By requiring the disclosure of clinical data, the bill aims to increase public trust in the vaccination process and provide individuals with the information they need to make informed decisions about their health.
Overall, Bill 119 hr 87 seeks to promote transparency and accountability in the vaccination process, particularly when it comes to COVID-19 vaccines for children and adolescents. By requiring the public disclosure of clinical data, the bill aims to ensure that vaccines recommended for use in this population are safe and effective.